期刊文献+

类风湿关节炎患者骨质疏松性骨折的临床研究 被引量:11

Clinical study of osteoporotic fracture in patients with rheumatoid arthritis
原文传递
导出
摘要 目的分析住院类风湿关节炎(RA)患者骨质疏松和骨质疏松性骨折(OPF)的发生情况和临床危险因素。方法收集2010--2011年确诊的住院RA患者272例,以x线片作为判断骨折的标准,采用双能量x射线骨密度测量仪(DEXA)测定203例RA患者和120名健康人股骨和腰椎的骨密度,同时详细记录RA患者各临床及实验室指标,并对其中169例RA患者的双手x线进行Sharp评分。采用t检验、Mann.Whitney检验、矿检验和多元Logistic回归进行统计学处理。结果①和健康对照组相比,RA患者在股骨和腰椎部位骨密度均明显降低(P如.01),其骨质疏松发生率32.00/0(65/203)明显高于健康对照组15.0%(18/120)(~=11.442,P=0.001)。272例RA患者中发生OPF的患者33例,发生率为12.1%;OPF组RA股骨区各部位骨密度较无OPF组明显降低(P〈0.01),但腰椎各部位骨密度差异无统计学意义(P〉0.05)。②服用糖皮质激素(GC)的RA患者中骨质疏松发生率为42.2%(46/109),高于未服用GC组中的20.2%(18/89)(X2=10.818,P=0.001);服用Gc的RA患者中OPF发生率为17.5%(24/137),高于未服用Gc组中的7.2%(9/125)钟=6.321,P=0.012)。③多元Logistic回归分析发现:年龄[D尺=I.050,P=0.001,95%CI(1.020,1.080)]、HAQ[OR=1.966,P=O.031,95%CI(1.064,3.631)]和GC日剂量【OR=1.075,P=O.031,95%C/(1.007,1.148)]为RA患者发生骨质疏松的危险因素;而年龄[OR=1.041,P=0.046,95%CI(1.001,1.084)]和骨质疏松[OR=3.484,P=0.016,95%CI(1.258,9.646)]为RA患者发生OPF的危险因素。结论RA患者骨质疏松和OPF发生率明显升高,且与年龄、RA疾病活动性和局部骨侵蚀、GC的使用密切相关。 Objective To-investigate the clinical features and related risk factors of osteoporosis (OP) and osteoporotic fracture (OPF) in patients with rheumatoid arthritis (RA). Methods Two hundred and seventy- two in-patients with RA between 2010-2011 were surveyed, X-ray was detected for the diagnosis of fracture. Bone mineral density(BMD) of proximal femur and lumbar vertebrae (L2~) in 203 patients were measured by dual energy X-ray absorptio-metry (DEXA), and the radiographic changes in both hands of 169 RA patients were assessed by Sharp scoring system. All the clinical and laboratory factors of RA were recorded in detail by rheumatologists. The results of 120 normal people were used as controls. T-test, Mann-whitney test, x2 test and Logistic regression were used for statistical analysis. Results (1) Compared to the normal group, the BMDs of RA patients at each measured location were significantly lower (P〈O.O1), the OP incidence was 32.0% (65/ 203), which was significantly higher than that of the normal group, which was 15.0% (181120) (X2=11.442, P=0.001 ). There were 33 cases of OPF among all 272 RA patients, and the occurrence rate was 12.1%. BMDs of the femur in RA with OPF were lower than those in RA without OPF (P〈0.01). (2) Incidence of OP in RA with glucoco-rticoid was 42.2%(46/109), which was higher than that in RA without glucocorticoid (20.2%, 18/89) (X2=10.818, P=0.001). Compared with RA without giucocorticoid, the incidence of OPF in RA with giucocorticoid elevated evidently [7.2% (91125) vs 17.5% (241137)] (Xz=6.321,P=0.O12). (3) Logistic regression (back-ward LR method) analysis found that the risk factors for OP in RA patients were age [OR=l.050, P=-0.001, 95%CI(1.020, 1.080)~, HAQ [OR=1.966, P=O.031, 95%CI (1.064, 3.631)], and glueocorticoid average daily dosage [OR=1.075, P=O.031, 95%CI (1.007, 1.148)1. The risk factors for OPF in RA patients were age OR=l.041, P=0.046, 95%CI (1.001, 1.084)] and OP EOR=3.484, P=0.016, 95%CI (1.258, 9.646)]. Conclusion RA patients have higher incidence of OP and OPF than general population. The incidence of OP and OPF are closely correlated with age, diseases activity, local bone erosion and the use of glucocortieosteroid.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2013年第5期341-345,共5页 Chinese Journal of Rheumatology
基金 安徽省自然科学基金(1308085MH163)
关键词 关节炎 类风湿 骨质疏松 骨折 Arthritis, rheumatoid Osteoporosis Fracture
  • 相关文献

参考文献15

  • 1Shimojima Y, Ishii W, Matsuda M, et al. Cytomegalovirus-in- duced infectious mononucleosis-like syndrome in a rheumatoid arthritis patient treated with methotrexate and infliximab. Intern Med, 2010, 9: 937-940.
  • 2类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1363
  • 3Roldan JF, del Rincon I, Escalante A, et al. Loss of cortical bone from the metacarpal diaphysis in patients with rheumatoid arthritis: independent effects of systemic inflammation and gluco- eortieoids. J Rheumatol, 2006, 33: 508-516.
  • 4Sinigaglia L, Varenna M, Girasole G, et al. Epidemiology of osteoporosis in rheumatic diseases. Rheum Dis Clin N Am, 2006, 32: 631-658.
  • 5中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊治指南(2011)[J].中国骨质疏松和骨矿盐疾病杂志,2011(1):2-17.
  • 6Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Bheumatol, 1999, 26: 743-745.
  • 7Haugeberg G, Uhlig T, Faleh JA, et al. Bone mineral density and frequency of osteoporosis in female patients with Rheumatoid Arthritis: results from 394 patients in the Os|o County rheuma- toid arthritis register. Arthritis Rheum, 2.000, 43: 522-530.
  • 8Tengstrand B, Hafstrtim J. Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sul- fasalazine treatmen but not with Sex hormones. J Rheumatol, 2002, 29 : 2299-2305.
  • 9Shankar S, Handa R, Aneja R, et al. Bone mineral density in Indian women with rheumatoid arthritis. Rheumatol Int, 2009, 29: 377-381.
  • 10徐胜前,徐建华,王芬,刘爽.糖皮质激素治疗类风湿关节炎的初步临床分析[J].中国实用医药,2008,3(24):16-18. 被引量:7

二级参考文献22

  • 1穆荣,栗占国.糖皮质激素在类风湿关节炎治疗中的应用[J].中华全科医师杂志,2005,4(3):143-145. 被引量:5
  • 2[1]Saag KG,Criswell LA,Sems KM,et al.Low-dose corticosteroids in rheumatoid arthritis.A meta-analysis of their moderate-term effectiveness.Arthritis Rheum,1996,39 (11):1818 -1825.
  • 3[2]Van Everdingen AA,Jacobs JW,Siewertsz Van Reesema DR,et al.Low-dose prednisone therapy for patients with early active rheumatoid arthritis:clinical efficacy,disease-modifying properties,and side effects:a randomized,double-blind,placebo-controllod clinical trial.Ann Intern Med,2002,136 (1):1-12.
  • 4[4]Kirwan JR.The effect of glucocorticoids on joint destruction in rheumatoid arthritis.The arthritis and rheumatism council low-dose glucocorticoid study group.N Engl J Med,1995,333 (3):142-146.
  • 5[5]American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines.Guidelines for the management of rheumatoid arthritis:2002 Update.Arthritis Rheum,2002,46 (2):328-346.
  • 6[7]De Bosscher K,Vanden Berghe W,Haegeman G.The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1:molecular mechanisms for gene repression.Endoer Rev,2003,24(4):488-522.
  • 7[8]Bijlsma JW,Boers M,Saag KG,et al.Glucocorticoids in the treatment of early and late Rheumatoid Arthritis.Ann Rheum.Dis,2003,62(11):1033-1037.
  • 8[10]Buttgerreit F,da Silva JA,Boers M,et al.Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens:current questions and tentative answers in rheumatology.Ann Rheum Dis,2002,61 (8):718-722.
  • 9[11]van Everdingen AA,Siewertsz Van Reesema DR,Jacobs JW,et al.Low-dosc glucccorticoids in early rheumatoid arthritis:discordant effects on bone mineral density and fractures Clin Exp Rheumatol,2003,21 (2):155-160.
  • 10Subramanian Shankar,Rohini Handa,Ritu Aneja,Vishal Marwaha,A. C. Ammini,V. Aprajita.Bone mineral density in Indian women with rheumatoid arthritis[J]. Rheumatology International . 2009 (4)

共引文献1385

同被引文献81

  • 1姜小鹰,杨金秋,胡蓉芳.原发性骨质疏松症高危人群筛检工具的建立及应用效果评价[J].国际护理学杂志,2006,25(5):353-357. 被引量:8
  • 2张菊英,吴涛,杨定焯,程晓光,周琦,卓铁军,张华寿,项静,王洪复,区品中。,刘建立,徐苓,黄公怡,黄琪仁,Barden HS,Weynand LS,Fqukner KG,孟迅吾,区品中.中国大陆地区妇女骨质疏松筛选工具探讨[J].中国修复重建外科杂志,2007,21(1):86-89. 被引量:26
  • 3周惠琼,姚如愚,RK Will.类风湿关节炎患者骨密度与疾病活动相关性的临床观察[J].中国骨质疏松杂志,2007,13(6):419-423. 被引量:14
  • 4高汉媛,李心宏.自拟益气活血方配合曲药治疗类风湿关节炎临床观察[J].中外健康文摘,2013(28):125-126.
  • 5Enneman AW, van der Velde N, de Jonge R, et al. The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures[ J ]. Bone, 2012, 50 (6) : 1401-1405.
  • 6Castafio-Betancourt MC, Rivadeneira F, Bierma-Zeinstra S, et al. Bone parameters across different types of hip osteoarthritis and their relationship to osteoporotic fracture risk [ J ]. Arthrit Rheumat, 2013, 65(3):693-700.
  • 7van der Heijde D.How to read radiographs according to the Sharp/van der Heijde method. The Journal of rheumatology . 2000
  • 8A.W. Enneman,N. van der Velde,R. de Jonge,S.G. Heil,L. Stolk,A. Hofman,F. Rivadeneira,M.C. Zillikens,A.G. Uitterlinden,J.B.J. van Meurs.??The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures(J)Bone . 2012 (6)
  • 9Minne H W,Leidig G,Wüster C,Siromachkostov L,Baldauf G,Bickel R,Sauer P,Lojen M,Ziegler R.A newly developed spine deformity index (SDI) to quantitate vertebral crush fractures in patients with osteoporosis. Bone and Mineral . 1988
  • 10Subramanian Shankar,Rohini Handa,Ritu Aneja,Vishal Marwaha,A. C. Ammini,V. Aprajita.??Bone mineral density in Indian women with rheumatoid arthritis(J)Rheumatology International . 2009 (4)

引证文献11

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部